FBRX Insider Trading Activity and SEC Form 4 Filings
FBRX insider trading summary
Over the past 12 months, insiders at Forte Biosciences, Inc. (FBRX) reported 1 open-market purchase worth $255K by 1 insider and no sales on SEC Form 4. Net insider buying was $255K.
Latest FBRX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 30, 2025 | Antony A Riley | Chief Financial Officer | Buy | $255K (9,680 @ $26.33) |
| Nov 21, 2024 | Antony A Riley | Chief Financial Officer | Buy | $125K (22,514 @ $5.55) |
| Dec 18, 2023 | Paul A. Wagner | See Remarks | Buy | $8K (10,000 @ $0.75) |
| Dec 14, 2023 | Paul A. Wagner | See Remarks | Buy | $7K (10,000 @ $0.72) |
| Dec 13, 2023 | Paul A. Wagner | See Remarks | Buy | $7K (10,520 @ $0.70) |
| Dec 12, 2023 | Paul A. Wagner | See Remarks | Buy | $3K (4,776 @ $0.65) |
| Dec 11, 2023 | Paul A. Wagner | See Remarks | Buy | $16K (25,000 @ $0.65) |
| Dec 8, 2023 | Paul A. Wagner | See Remarks | Buy | $9K (15,000 @ $0.62) |
| Dec 7, 2023 | Paul A. Wagner | See Remarks | Buy | $21K (36,203 @ $0.58) |
| Nov 22, 2023 | Paul A. Wagner | See Remarks | Buy | $172 (400 @ $0.43) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.